CTRI/2023/09/057410
Completed
未知
Targeted Therapy in Metastatic Colorectal Cancer (mCRC) in India: A Real-world, Retrospective Observational Study - NI
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: C260- Malignant neoplasm of intestinal tract, part unspecified
- Sponsor
- Dr. Reddy’s Laboratories Ltd.
- Enrollment
- 100
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Male and female patients, \= 18 years of age
- •Histologically confirmed diagnosis of mCRC
- •Patients who received bevacizumab, cetuximab, or panitumumab targeted therapies for the medical management of their disease in the first\-line setting
Exclusion Criteria
- •Patients with follow\-up data less than 6 months post\-initiation of targeted therapies
- •Patients whose treatment with targeted therapy began before 2015 or more recently than 30 days prior to the ethics committee approval
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Therapy for metastatic colorectal cancerEUCTR2011-003217-41-ATArbeitsgemeinschaft medikamentöse Tumortherapie gemeinnützige GmbH50
Active, not recruiting
Phase 1
A randomized phase 3 study of treatment strategies for patients with colon cancer with metastases only in the liver, which is (at this moment) not eligible for surgical treatment. A study of the Dutch Colorectal Cancer Group (DCCG).EUCTR2013-005435-24-NLDutch Colorectal Cancer Group584
Recruiting
Phase 3
Treatment strategies in colorectal cancer patients with initially unresectable liver-only metastases. CAIRO5 a randomized phase 3 study of the Dutch Colorectal Cancer Group (DCCG)Bowel CancerColorectal cancer10017991NL-OMON54605Dutch Colorectal Cancer Group584
Terminated
Phase 3
Tailored Treatment in Metastatic Colorectal CancerMetastatic Colorectal CancerNCT00396487Vejle Hospital1
Completed
Not Applicable
Colorectal Cancer Umbrella Protocol - Assessment of Targeted Therapies Against Colorectal Cancer (ATTACC Program) Screening ProtocolColorectal CancerNCT01196130M.D. Anderson Cancer Center1,275